IL6 and type 2 diabetes mellitus: In this study, we observed for the first time that the combination of metformin and dulaglutide significantly improved arterial elasticity; increased the number of EPCs and NO levels; decreased IL-6 levels; and improved EPCs’ proliferation, adhesion, migration, and tubule formation abilities in T2DM patients with poor blood glucose control with metformin alone.